Last reviewed · How we verify

NCT02457429

A Validation Study of the Dx-pH Probe in Children for the Detection of Extra-oesophageal Reflux

Completed NA Last updated 18 January 2019
What this trial tests

NA trial testing Experiemental diagnostic procedure: Dx-pH measurement system in Gastro-oesophageal Reflux in 16 participants. Completed in 28 April 2017.

Timeline
22 March 2013
Primary endpoint
28 April 2017
28 April 2017

Quick facts

Lead sponsorManchester University NHS Foundation Trust
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment16
Start date22 March 2013
Primary completion28 April 2017
Estimated completion28 April 2017
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

Manchester University NHS Foundation Trust

Who can join

Adults 1 to 16, any sex, with Gastro-oesophageal Reflux. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Gastro-oesophageal reflux (GORD) and its extraoesophageal manifestations present with a variety of symptoms in both adult and paediatric populations. In children the effects of refluxate above the upper oesophageal sphincter (UES) has been implicated as a contributory factor in the underlying pathological processes of a number of conditions including apnoea, asthma, chronic cough, subglottic stenosis, chronic rhinosinusitis and otitis media. The absence of typical symptoms in addition to the inability to obtain a formal symptom history from a young paediatric population contributes to the difficulty in establishing a diagnosis. At present there are no studies or data directly measuring extraoesophageal reflux and its correlation to oesophageal pH monitoring in children. The use of twenty-four hour oesophageal pH monitoring is regarded as the established technique for diagnosis of GORD, however this technique has been less reliable for detecting extra-oesophageal reflux. The investigators intend to use the Dx-pH Measurement system, a sensitive and minimally invasive transnasal device, to assess the feasibility and validate its use in a paediatric population.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Gastro-oesophageal Reflux

Currently open trials in the same condition.

Other Manchester University NHS Foundation Trust trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02457429.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing